Bowel cancer immunotherapy clinical trial follow-up shows zero relapses

MedicalXpress | 四月 20, 2026

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of follow-up, according to new results from the NEOPRISM-CRC clinical trial led by a team from UCL and UCLH.